Imexpharm Corporation reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was VND 491,101.3 million compared to VND 479,272.05 million a year ago. Net income was VND 61,920.25 million compared to VND 77,826.3 million a year ago.

Basic earnings per share from continuing operations was VND 752 compared to VND 945 a year ago.